Invo Bioscience ( OTCMKTS:IVOB ) and Repro-Med Systems ( OTCMKTS:REPR ) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, profitability and earnings.
Analyst Recommendations
This is a summary of recent recommendations and price targets for Invo Bioscience and Repro-Med Systems, as provided by MarketBeat.com.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Invo Bioscience 0 0 0 0 N/A Repro-Med Systems 0 0 0 0 N/A
Earnings & Valuation
This table compares Invo Bioscience and Repro-Med Systems’ top-line revenue, earnings per share and valuation.
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Invo Bioscience $490,000.00 112.89 -$3.08 million N/A N/A Repro-Med Systems $17.35 million 3.57 $910,000.00 N/A N/A Repro-Med Systems has higher revenue and earnings than Invo Bioscience.
Insider & Institutional Ownership
0.0% of Invo Bioscience shares are owned by institutional investors. Comparatively, 17.7% of Repro-Med Systems shares are owned by institutional investors. 40.0% of Repro-Med Systems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Profitability
This table compares Invo Bioscience and Repro-Med Systems’ net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets Invo Bioscience -585.49% N/A -117.54% Repro-Med Systems 2.38% 12.29% 10.30% Risk & Volatility
Invo Bioscience has a beta of -0.75, indicating that its stock price is 175% less volatile than the S&P 500. Comparatively, Repro-Med Systems has a beta of -0.79, indicating that its stock price is 179% less volatile than the S&P 500.
Summary
Repro-Med Systems beats Invo Bioscience on 7 of the 9 factors compared between the two stocks.
About Invo Bioscience
INVO Bioscience, Inc. provides solutions in assisted reproductive technologies to the reproductive health care community in the United States, Asia, South America, Central America, Europe, the Middle East, India and Africa. The company offers the INVOcell device that is used in infertility treatment for the incubation of eggs and sperm during fertilization, and early embryo development. It also offers INVOcell Retention Device, a single-use, modified diaphragm that includes holes to allow for natural drainage of vaginal fluids; and INVO Holding/Warming Blocks that acts as a tool for viewing and retrieving the embryos from the inner chamber. The company sells its products to physicians directly; and IVF centers, medical practices, and physicians through distributors. INVO Bioscience, Inc. is based in Medford, Massachusetts.
About Repro-Med Systems
Repro Med Systems, Inc., doing business as RMS Medical Products, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and RMS precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was founded in 1980 and is headquartered in Chester, New York.
